CIK 0001357874 · Non-accelerated filer<br>Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- operating
- Phone
- 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-26 | Buehler Kevin Director | Purchase | +4,523 | $4.67 | $21K | 13,235 |
| 2025-03-25 | Germano Geno J Director | Purchase | +3,250 | $5.30 | $17K | 11,057 |
| 2025-03-24 | Amoroso Michael President and CEO | Sale 10b5-1 | −964 | $5.56 | $5K | 109,540 |
| 2025-03-21 | Amoroso Michael President and CEO | Option exercise 10b5-1 | +3,417 | 110,504 | ||
| 2025-03-21 | Amoroso Michael President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −3,417 | 0 | ||
| 2025-03-04 | Scimeca Dario General Counsel and Secretary | Sale 10b5-1 | −272 | $4.91 | $1K | 25,000 |
| 2025-03-04 | SMITH J. JEFFERSON Chief Research Officer | Sale 10b5-1 | −154 | $4.91 | $756 | 87,805 |
| 2025-03-03 | Scimeca Dario General Counsel and Secretary | Option exercise 10b5-1 | +919 | 25,272 | ||
| 2025-03-03 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units 10b5-1 | −919 | 0 | ||
| 2025-03-03 | SMITH J. JEFFERSON Chief Research Officer | Option exercise 10b5-1 | +519 | 87,959 | ||
| 2025-03-03 | SMITH J. JEFFERSON Chief Research Officer | Option exercise · Restricted Stock Units 10b5-1 | −519 | 0 | ||
| 2025-03-03 | Kelly John Alexander Chief Financial Officer | Option exercise | +1,702 | 86,256 | ||
| 2025-03-03 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units | −1,702 | 0 | ||
| 2025-01-22 | Scimeca Dario General Counsel and Secretary | Sale 10b5-1 | −8,928 | $4.79 | $43K | 24,353 |
| 2025-01-22 | SMITH J. JEFFERSON Chief Research Officer | Sale 10b5-1 | −10,287 | $4.79 | $49K | 87,440 |
| 2025-01-21 | Amoroso Michael President and CEO | Sale 10b5-1 | −36,838 | $4.67 | $172K | 107,087 |
| 2025-01-20 | Scimeca Dario General Counsel and Secretary | Option exercise 10b5-1 | +25,312 | 33,281 | ||
| 2025-01-20 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units 10b5-1 | −1,977 | 1,978 | ||
| 2025-01-20 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units 10b5-1 | −8,427 | 16,850 | ||
| 2025-01-20 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units 10b5-1 | −14,908 | 29,815 |
Page 6 of 11 · 210 trades